![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1996-3181|10|1|68-81
ISSN: 1871-5273
Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.10, Iss.1, 2011-02, pp. : 68-81
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novel therapeutic agents for multiple sclerosis
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 12, 1999-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Therapeutic developments in multiple sclerosis
By Goodin D.S.
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. :